Semler Scientific, Inc. (NASDAQ:SMLR) Shares Purchased by Stifel Financial Corp

Stifel Financial Corp increased its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 107.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,141 shares of the company's stock after acquiring an additional 27,062 shares during the period. Stifel Financial Corp owned about 0.56% of Semler Scientific worth $2,816,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MetLife Investment Management LLC bought a new position in shares of Semler Scientific during the fourth quarter valued at about $163,000. Capital International Investors bought a new stake in shares of Semler Scientific in the 4th quarter worth about $30,813,000. NewEdge Advisors LLC increased its stake in shares of Semler Scientific by 318.3% during the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after buying an additional 557 shares during the period. EAM Investors LLC purchased a new stake in shares of Semler Scientific during the fourth quarter valued at $805,000. Finally, Raymond James Financial Inc. acquired a new stake in Semler Scientific in the 4th quarter valued at $1,939,000. 49.37% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Lake Street Capital boosted their target price on Semler Scientific from $40.00 to $71.00 and gave the company a "buy" rating in a report on Friday, January 24th.

Semler Scientific Price Performance

Shares of SMLR stock traded down $1.04 on Friday, hitting $34.20. The company's stock had a trading volume of 252,336 shares, compared to its average volume of 423,359. The firm's fifty day moving average price is $35.13 and its 200-day moving average price is $46.41. The stock has a market capitalization of $328.22 million, a price-to-earnings ratio of 6.97 and a beta of 1.33. Semler Scientific, Inc. has a fifty-two week low of $21.03 and a fifty-two week high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.